Friday, April 10, 2015

Control and Coordination,Neurons and ANIMALS – NERVOUS SYSTEM and Sodium pump could act as molecular light switch

ANIMALS – NERVOUS SYSTEM
Touching a hot object is an urgent and dangerous situation for us. We need to detect it,and respond to it. How do we detect that we are touching a hot object? All information from our environment is detected by the specialised tips of some nerve cells. These receptors are usually located in our sense organs, such as the inner ear, the nose, the tongue, and so on. So gustatory receptors will detect taste while olfactory receptors will detect smell This information, acquired at the end of the dendritic tip of a nerve cell as shown below sets off a chemical reaction that creates an electrical impulse.

(a) Structure of neuron, (b) Neuromuscular junction as shown above

This impulse travels from the dendrite to the cell body, and then along the axon to its end. At the end of the axon, the electrical impulse sets off the release of some chemicals. These chemicals cross the gap, or synapse, and start a similar electrical impulse in a dendrite of the next neuron. This is a general scheme of how nervous impulses travel in the body. A similar synapse finally allows delivery of such impulses from neurons to other cells, such as muscles cells or gland.

It is thus no surprise that nervous tissue is made up of an organised network of nerve cells or neurons, and is specialised for conducting information via electrical impulses from one part of the body to another.

Look at aboveFig (a) and identify the parts of a neuron (i) where information is acquired, (ii) through which information travels as an electrical impulse, and (iii) where this impulse must be converted into a chemical signal for onward transmission.


How Sodium pump could act as molecular light switch
The surface of the KR2 complex shown from the side. Each of the five KR2 molecules binds and transports a sodium ion (purple) across the membrane. Credit: Forschungszentrum Jülich/IBS Grenoble

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp


The surface of the KR2 complex shown from the side. Each of the five KR2 molecules binds and transports a sodium ion (purple) across the membrane. Credit:Forschungszentrum Jülich/IBS Grenoble

Scientists from Jülich, Grenoble, Frankfurt and Moscow uncovered the atomic structure of KR2,  light-driven transporter for sodium ions which had only recently been discovered.Based on the structural information the team then identified a simple way to turn KR2 from a sodium- into a potassium pump using simple means. Integrated into neurons,this could make KR2 a valuable tool for optogenetics, a new field of research that uses light-sensitive proteins as molecular switches to precisely control the activity of neurons and other electrically excitable cells using light impulses.

In 2013, scientists made an unexpected discovery while investigating  the marine bacterium Krokinobacter eikastus. In its cellular membrane, the bacterium had a previously unknown type of ion transporter. The protein, which was dubbed KR2,belongs to a group of light-sensitive proteins that  have become the basis of the research field of optogenetics When exposed to light, these proteins allow charged particles to flow flow into the cell or transport them outside the cell.

Integrating these ion transporters into the neuronal membrane makes it possible  to alter their state of charge using light impulses, thus enabling their activity to be precisely controlled. This method quickly became established in the neurosciences,in particular. However, only a few proteins are currently available for this and each of these proteins was only permeable to certain ions.

KR2 transports positively charged sodium ions out of the cell,  which is a feature that so far had been missing in the toolkit of optogenetics. However, until now neither the exact atomic structure nor the ion transport mechanism had been known_which is an important prerequisite for utilizing KR2 and adapting it for specific applications.. This challenge awakened the interest of a team of structural biologists headed by Valentin Gordeliy,who heads research groups at the Institute of Complex Systems (ICS-6) at Forschungszentrum Jülich, Germany, at the Institute de Biologie
in Grenoble, France, and at the Moscow.Institute of Physics and Technology in Russia. Using X-ray crystallography,, the team obtained the first high-resolution 3D structural images of the single protein and the five-part complex  that the KR2 molecule spontaneously forms under physiological conditions.
The structure of KR2 has many unique features," says Ivan Gushchin,one of the lead authors of the study and a postdoc of Gordeliy. One of these features is a short protein helix capping the outfacing opening of the pump like a lid. A feature of KR2, that the scientists were particularly interested in was the unusual
structure of the inward facing ion-uptake cavity, which was found to be unusually large and protruding from the protein surface. We hypothesized that this structure could act as a kind of filter causing the selectivity of KR2 for sodium ions," Gushchin explains. 

To put this idea to the test, Gordeliy´s team changed the structure by swapping specific amino acids at the site in question through targeted mutations. Not only did KR2 indeed lose
its sodium-pumping ability;but also one of the mutations seemed to turn KR2 into a light-driven potassium pump – the first of its kind.To accurately prove this observation the team performed a series of electrophysiological experiments with with the purified protein in collaboration with Ernst Bamberg at the Max Planck  Institute of Biophysics in Frankfurt am Main, who is an expert on membrane proteins and one of the founders of optogenetics.

For potential optogenetic application, this result is especially interesting, "In neurons, transporting potassium ions from the cell is the natural mechanism of deactivation.. Normally, an activated neuron will release them through passive potassium channels in the membrane." With a light-activated, active potassium pump this process could be precisely controlled". This would make KR2 a very effective off-switch for neurons.
Now, ways of integrating the pump into different types of cells need to be developed. "In combination with the light-activated Channelrhodopsin 2,which is used in labs worldwide as a molecular off-switch, the KR2 potassium pump would then form a perfect pair of tools for the precise control of nerve cell activity.

To put this idea to the test, Gordeliy´s team changed the structure by swapping specific amino acids at the site in question through targeted mutations. Not only did KR2 indeed lose its sodium-pumping ability; but also one of the mutations seemed to turn KR2 into a light-driven – the first of its kind. To accurately prove this observation the team performed a series of electrophysiological experiments with the purified protein in collaboration with Ernst Bamberg at the Max Planck Institute of Biophysics in Frankfurt am Main, who is an expert on membrane proteins and one of the founders of optogenetics.

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp

Gordeliy. One of these features is a short protein helix capping the outfacing opening of the pump like a lid

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp
optogenetics. However, until now neither the exact nor the ion transport mechanism

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp

belongs to a group of that have become the basis of the research field of optogenetics

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp


In 2013, scientists made an unexpected discovery while investigating the marine bacterium Krokinobacte

Read more at: http://phys.org/news/2015-04-sodium-molecular.html#jCp





Researchers convert ethane to ethanol with an efficiency that could cut natural-gas refining costs

The Molecular Foundry is a national user facility, one of the U.S. Department of Energy's (DOE's) nanoscale science research centers. It is located at Lawrence Berkeley National Laboratory and supported by the DOE's Office of Basic Energy Sciences.The Molecular Foundry serves hundreds of academic,industrial and government scientists from around the world each year who come to the Foundry to perform multidisciplinary research beyond the scope of their own laboratories and to develop science and technology strategies in energy, electronics, materials science, and biology.The world-class scientists at the Molecular Foundry have expertise across the state-of-the-art,unique instrumentation in a broad range of disciplines.

Refining natural gas into an easy-to-transport, easy-to-store liquid so far has been a challenge. But now, a new material, designed and patented by researchers working at the Molecular Foundry nanoscience research center, is making this process a little easier. Their findings could pave the way for the adoption of cheaper, cleaner-burning fuels.

Natural gasses, like ethane and methane, are hard to store and transport.However, by converting them to liquids specifically,liquid alcohols, they could be more easily stored, transported and used as fuels. Ethanol, the liquid form of ethane, is a particularly attractive form of liquid fuel because it burns cleaner and provides greater energy than its alternatives.Unfortunately, current methods for making ethanol from ethane require extreme heat (approximately 400-600 °F), making it a very expensive fuel.

To lower the temperature, and thus lower costs,a research team at the Molecular Foundry created a collection of tiny cages,a metal-organic framework (MOF) which speeds the chemical reaction that turns ethane into ethanol. In addition to their catalyzing ability of quickly turning one chemical into another, MOFs can also act as a chemical filter,capturing and holding selected molecules. By using a specially designed MOF—one in which a kind of iron was added inside the tiny molecular cages—the researchers were able to reduce the need for extreme heat,converting to alcohol at just 167°F. This reduces costs involved in making the preferred form of fuel.




converting to alcohol at just 167°F. This reduces costs involved in making the preferred form of fuel.

Read more at: http://phys.org/news/2015-04-ethane-ethanol-efficiency-natural-gas-refining.html#jCp
catalyzing ability of quickly turning one chemical into another, MOFs can also act as a chemical filter,

Read more at: http://phys.org/news/2015-04-ethane-ethanol-efficiency-natural-gas-refining.html#jCp


To lower the temperature, and thus lower costs, a research team at the Molecular Foundry created a collection

Read more at: http://phys.org/news/2015-04-ethane-ethanol-efficiency-natural-gas-refining.html#jCp

But now, a new material, designed and patented by researchers working at the Molecular Foundry nanoscience research center, is making this

Read more at: http://phys.org/news/2015-04-ethane-ethanol-efficiency-natural-gas-refining.html#jCp

The Molecular Foundry is a national user facility, one of the U.S. Department of Energy's (DOE's) nanoscale science research centers. It is located at Lawrence Berkeley National Laboratory and supported by the DOE's Office of Basic Energy Sciences. The Molecular Foundry serves hundreds of academic, industrial and government scientists from around the world each year who come to the Foundry to perform multidisciplinary research beyond the scope of their own laboratories and to develop science and technology strategies in energy, electronics, materials science, and biology. The world-class scientists at the Molecular Foundry have expertise across the state-of-the-art, unique instrumentation in a broad range of disciplines.

Read more at: http://phys.org/news/2015-04-ethane-ethanol-efficiency-natural-gas-refining.html#jCp

Tuesday, April 7, 2015

Nano packages for anti-cancer drug delivery,Cancer stem cells are resistant to chemotherapy and consequently tend to remain in the body even after a course of treatment has finished, where they can often trigger cancer recurrence or metastasis.

Cancer stem cells are resistant to chemotherapy and consequently remain inside a body even after chemotherapy even after the course of treatment is finished where they can trigger cancer recurrence or metastasis.

A new study by researchers from the A*STAR Institute of Bioengineering and Nanotechnology has found that using nanoparticles to deliver an anti-cancer drug that simultaneously kills cancer cells and cancer stem cells significantly reduces the recurrence  and metastasis of lung cancer.

 

The drug phenformin is very effective  against cancer stem cells.It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines.However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal cancer cells and cancer stem cells.

 

Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling  polymer nanoparticles to deliver the drug .

In the first study to use to deliver phenformin to target both cancer cells and cancer stem cells, Yang

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp

 

 

The drug phenformin is very effective against cancer stem cells. It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines. However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal and cancer stem cells. Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling polymer to deliver the drug.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp

 

The drug phenformin is very effective against cancer stem cells. It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines. However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal and cancer stem cells. Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling polymer to deliver the drug.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
The drug phenformin is very effective against cancer stem cells. It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines. However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal and cancer stem cells. Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling polymer to deliver the drug.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
The drug phenformin is very effective against cancer stem cells. It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines. However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal and cancer stem cells. Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling polymer to deliver the drug.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
The drug phenformin is very effective against cancer stem cells. It is related to the popular anti-diabetic drug metformin but is 50 times more potent against cancer cell lines. However, phenformin is too toxic in its free form to be administered to patients at the doses required to kill both normal and cancer stem cells. Now, Yi Yan Yang and her colleagues at the Institute of Bioengineering and Nanotechnology in Singapore have found a way to overcome this problem—using self-assembling polymer to deliver the drug.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
simultaneously kills cancer cells and cancer stem cells significantly reduces the recurrence and metastasis of lung cancer

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
simultaneously kills cancer cells and cancer stem cells significantly reduces the recurrence and metastasis of lung cancer

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp
Institute of Bioengineering and Nanotechnology has found that using nanoparticles to deliver an anti-cancer drug that simultaneously kills cancer cells and cancer stem cells significantly reduces the recurrence and metastasis of lung cancer.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp

.

Cancer stem cells are resistant to chemotherapy and consequently tend to remain in the body even after a course of treatment has finished, where they can often trigger cancer recurrence or metastasis. A new study by researchers from the A*STAR Institute of Bioengineering and Nanotechnology has found that using nanoparticles to deliver an anti-cancer drug that simultaneously kills cancer cells and cancer stem cells significantly reduces the recurrence and metastasis of lung cancer.

Read more at: http://phys.org/news/2015-03-nano-packages-anti-cancer-drug-delivery.html#jCp